Autek China Inc (300595) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.054x

Based on the latest financial reports, Autek China Inc (300595) has a cash flow conversion efficiency ratio of 0.054x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥291.97 Million ≈ $42.72 Million USD) by net assets (CN¥5.43 Billion ≈ $794.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Autek China Inc - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Autek China Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Autek China Inc (300595) total liabilities for a breakdown of total debt and financial obligations.

Autek China Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Autek China Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Intapp Inc
NASDAQ:INTA
0.028x
GeneDx Holdings Corp.
NASDAQ:WGS
0.054x
Tabcorp Holdings Ltd
AU:TAH
0.075x
Galapagos NV ADR
NASDAQ:GLPG
-0.013x
Diamondrock Hospitality Company Common Stock
NYSE:DRH
0.047x
TIANQI LITHIUM H YC 1
F:2220
N/A
Beach Energy Ltd
AU:BPT
0.140x
Zhongli Science and Technology Group Co Ltd
SHE:002309
0.184x

Annual Cash Flow Conversion Efficiency for Autek China Inc (2012–2024)

The table below shows the annual cash flow conversion efficiency of Autek China Inc from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Autek China Inc.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥5.14 Billion
≈ $752.68 Million
CN¥684.91 Million
≈ $100.22 Million
0.133x -13.28%
2023-12-31 CN¥4.71 Billion
≈ $689.38 Million
CN¥723.38 Million
≈ $105.85 Million
0.154x +8.27%
2022-12-31 CN¥4.60 Billion
≈ $672.46 Million
CN¥651.72 Million
≈ $95.37 Million
0.142x -42.92%
2021-12-31 CN¥2.54 Billion
≈ $371.11 Million
CN¥630.09 Million
≈ $92.20 Million
0.248x +29.87%
2020-12-31 CN¥1.99 Billion
≈ $291.37 Million
CN¥380.94 Million
≈ $55.74 Million
0.191x -0.11%
2019-12-31 CN¥1.44 Billion
≈ $210.40 Million
CN¥275.37 Million
≈ $40.29 Million
0.192x +39.58%
2018-12-31 CN¥1.08 Billion
≈ $158.39 Million
CN¥148.52 Million
≈ $21.73 Million
0.137x -22.98%
2017-12-31 CN¥812.34 Million
≈ $118.87 Million
CN¥144.71 Million
≈ $21.18 Million
0.178x -48.27%
2016-12-31 CN¥315.94 Million
≈ $46.23 Million
CN¥108.80 Million
≈ $15.92 Million
0.344x +8.82%
2015-12-31 CN¥253.53 Million
≈ $37.10 Million
CN¥80.23 Million
≈ $11.74 Million
0.316x -1.81%
2014-12-31 CN¥192.08 Million
≈ $28.11 Million
CN¥61.91 Million
≈ $9.06 Million
0.322x -11.92%
2013-12-31 CN¥145.86 Million
≈ $21.34 Million
CN¥53.37 Million
≈ $7.81 Million
0.366x +100.78%
2012-12-31 CN¥105.24 Million
≈ $15.40 Million
CN¥19.18 Million
≈ $2.81 Million
0.182x --

About Autek China Inc

SHE:300595 China Medical Instruments & Supplies
Market Cap
$1.89 Billion
CN¥12.91 Billion CNY
Market Cap Rank
#6482 Global
#1467 in China
Share Price
CN¥14.42
Change (1 day)
+0.91%
52-Week Range
CN¥13.78 - CN¥19.38
All Time High
CN¥106.29
About

Autek China Inc. engages in the research and development, production, and sale of hard contact lens products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It also provides ophthalmic … Read more